| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Lassa virus | 2 | 2019 | 99 | 0.95 | Why? |
| Hexosyltransferases | 1 | 2019 | 3 | 0.85 | Why? |
| Viral Fusion Proteins | 4 | 2019 | 399 | 0.75 | Why? |
| Junin virus | 1 | 2018 | 28 | 0.74 | Why? |
| Respiratory Tract Neoplasms | 1 | 2017 | 1 | 0.74 | Why? |
| Lassa Fever | 1 | 2019 | 88 | 0.73 | Why? |
| Papillomavirus E7 Proteins | 1 | 2017 | 20 | 0.72 | Why? |
| Respiratory Syncytial Virus Vaccines | 1 | 2019 | 104 | 0.70 | Why? |
| Mannose | 1 | 2017 | 68 | 0.68 | Why? |
| Human papillomavirus 16 | 1 | 2017 | 95 | 0.66 | Why? |
| Cancer Vaccines | 1 | 2017 | 136 | 0.62 | Why? |
| Receptors, Immunologic | 1 | 2020 | 555 | 0.62 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2019 | 691 | 0.56 | Why? |
| Glycoproteins | 1 | 2019 | 615 | 0.56 | Why? |
| Encephalitis Virus, Japanese | 3 | 2017 | 63 | 0.50 | Why? |
| Lung Injury | 1 | 2019 | 919 | 0.39 | Why? |
| Oxidoreductases | 2 | 2020 | 136 | 0.38 | Why? |
| Membrane Proteins | 1 | 2019 | 1733 | 0.38 | Why? |
| Papillomavirus Infections | 1 | 2017 | 861 | 0.37 | Why? |
| Antibodies, Neutralizing | 3 | 2020 | 25288 | 0.35 | Why? |
| HeLa Cells | 3 | 2020 | 1303 | 0.34 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.34 | Why? |
| High-Throughput Screening Assays | 4 | 2021 | 1783 | 0.33 | Why? |
| PrPC Proteins | 1 | 2005 | 3 | 0.32 | Why? |
| Crystallins | 1 | 2005 | 3 | 0.32 | Why? |
| Mutagenesis, Site-Directed | 3 | 2021 | 449 | 0.29 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.28 | Why? |
| Vero Cells | 13 | 2021 | 14117 | 0.28 | Why? |
| Antiviral Agents | 14 | 2021 | 41703 | 0.28 | Why? |
| Drug Evaluation, Preclinical | 6 | 2021 | 3347 | 0.26 | Why? |
| Membrane Glycoproteins | 4 | 2018 | 2273 | 0.25 | Why? |
| Cysteine Endopeptidases | 3 | 2020 | 1557 | 0.24 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.23 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.23 | Why? |
| Gene Knockout Techniques | 2 | 2020 | 347 | 0.23 | Why? |
| Pyrogallol | 1 | 2021 | 19 | 0.23 | Why? |
| Animals | 22 | 2021 | 78931 | 0.22 | Why? |
| Mice | 10 | 2021 | 21357 | 0.22 | Why? |
| Sincalide | 1 | 2020 | 10 | 0.22 | Why? |
| Alkenes | 1 | 2020 | 41 | 0.21 | Why? |
| Suramin | 1 | 2021 | 76 | 0.21 | Why? |
| Encephalitis, Japanese | 2 | 2017 | 58 | 0.21 | Why? |
| Biological Assay | 2 | 2020 | 367 | 0.20 | Why? |
| Viral Envelope Proteins | 4 | 2018 | 3539 | 0.20 | Why? |
| Cation Transport Proteins | 1 | 2019 | 53 | 0.20 | Why? |
| Fluorouracil | 1 | 2020 | 169 | 0.20 | Why? |
| Viral Nonstructural Proteins | 4 | 2021 | 4810 | 0.19 | Why? |
| Pyrethrins | 1 | 2018 | 28 | 0.19 | Why? |
| Flavonoids | 2 | 2021 | 492 | 0.19 | Why? |
| Flavanones | 1 | 2020 | 141 | 0.19 | Why? |
| Dihydropyridines | 1 | 2018 | 29 | 0.19 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.19 | Why? |
| Tumor Suppressor Proteins | 1 | 2019 | 165 | 0.18 | Why? |
| Protein Isoforms | 1 | 2019 | 347 | 0.18 | Why? |
| Phlebovirus | 1 | 2019 | 106 | 0.18 | Why? |
| Virus Internalization | 5 | 2020 | 7921 | 0.18 | Why? |
| Pichia | 1 | 2017 | 42 | 0.18 | Why? |
| Virus Replication | 10 | 2021 | 14331 | 0.17 | Why? |
| Insect Proteins | 1 | 2017 | 39 | 0.17 | Why? |
| Protein Subunits | 1 | 2020 | 755 | 0.17 | Why? |
| Drug Discovery | 3 | 2020 | 3092 | 0.17 | Why? |
| Nerve Tissue Proteins | 1 | 2019 | 319 | 0.17 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.17 | Why? |
| Polyphenols | 1 | 2020 | 283 | 0.16 | Why? |
| Sendai virus | 1 | 2017 | 111 | 0.16 | Why? |
| Cell Line | 7 | 2020 | 12040 | 0.16 | Why? |
| Quantum Dots | 1 | 2018 | 129 | 0.16 | Why? |
| Yellow fever virus | 1 | 2018 | 205 | 0.16 | Why? |
| Synthetic Biology | 1 | 2017 | 99 | 0.16 | Why? |
| Respirovirus Infections | 1 | 2017 | 90 | 0.16 | Why? |
| HEK293 Cells | 5 | 2021 | 8394 | 0.15 | Why? |
| Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.15 | Why? |
| Protease Inhibitors | 3 | 2021 | 3630 | 0.15 | Why? |
| Virus Release | 1 | 2017 | 253 | 0.15 | Why? |
| Thiazoles | 1 | 2020 | 496 | 0.15 | Why? |
| Receptors, Cell Surface | 1 | 2019 | 586 | 0.15 | Why? |
| Glycosylation | 1 | 2019 | 1255 | 0.15 | Why? |
| Host-Pathogen Interactions | 5 | 2021 | 11041 | 0.14 | Why? |
| Betacoronavirus | 10 | 2020 | 204454 | 0.14 | Why? |
| Mice, Inbred BALB C | 3 | 2020 | 5814 | 0.14 | Why? |
| Respiratory Syncytial Viruses | 1 | 2019 | 612 | 0.14 | Why? |
| Protein Engineering | 1 | 2017 | 536 | 0.14 | Why? |
| Mosquito Vectors | 1 | 2017 | 351 | 0.13 | Why? |
| Drug Design | 3 | 2021 | 2627 | 0.13 | Why? |
| Aedes | 1 | 2017 | 380 | 0.13 | Why? |
| Mice, Inbred C57BL | 3 | 2021 | 5542 | 0.13 | Why? |
| Epitope Mapping | 1 | 2018 | 1240 | 0.13 | Why? |
| Protein Structure, Tertiary | 4 | 2021 | 1565 | 0.13 | Why? |
| RNA Viruses | 1 | 2020 | 824 | 0.12 | Why? |
| Protein Binding | 4 | 2020 | 11430 | 0.12 | Why? |
| Inhibitory Concentration 50 | 3 | 2021 | 907 | 0.12 | Why? |
| SARS Virus | 7 | 2020 | 13021 | 0.12 | Why? |
| Autophagy | 1 | 2018 | 960 | 0.10 | Why? |
| CRISPR-Cas Systems | 1 | 2019 | 1397 | 0.10 | Why? |
| Enzyme Inhibitors | 1 | 2021 | 1881 | 0.10 | Why? |
| Antibodies, Viral | 3 | 2020 | 51949 | 0.10 | Why? |
| Influenza A virus | 2 | 2020 | 2234 | 0.10 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2019 | 1234 | 0.10 | Why? |
| Proteomics | 2 | 2017 | 2481 | 0.09 | Why? |
| Models, Molecular | 2 | 2020 | 7616 | 0.09 | Why? |
| Dendritic Cells | 1 | 2017 | 1330 | 0.09 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.09 | Why? |
| Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 238 | 0.09 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.09 | Why? |
| MicroRNAs | 1 | 2021 | 1787 | 0.09 | Why? |
| Immunization | 1 | 2017 | 2019 | 0.09 | Why? |
| Binding Sites | 4 | 2021 | 6201 | 0.09 | Why? |
| DNA, Catalytic | 1 | 2007 | 48 | 0.09 | Why? |
| Zika Virus | 2 | 2017 | 1924 | 0.08 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.08 | Why? |
| Immune Evasion | 1 | 2017 | 2081 | 0.08 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.08 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Feces | 1 | 2020 | 4235 | 0.08 | Why? |
| Evolution, Molecular | 2 | 2018 | 3691 | 0.08 | Why? |
| Two-Hybrid System Techniques | 1 | 2005 | 116 | 0.08 | Why? |
| Pharmaceutical Preparations | 1 | 2020 | 1897 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.07 | Why? |
| 5' Untranslated Regions | 1 | 2007 | 375 | 0.07 | Why? |
| Chiroptera | 1 | 2020 | 3530 | 0.07 | Why? |
| DNA Fragmentation | 1 | 2004 | 67 | 0.07 | Why? |
| Drugs, Chinese Herbal | 1 | 2020 | 2760 | 0.07 | Why? |
| Protein Folding | 1 | 2005 | 270 | 0.07 | Why? |
| Viral Core Proteins | 1 | 2004 | 134 | 0.07 | Why? |
| Catalytic Domain | 2 | 2021 | 1757 | 0.07 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.06 | Why? |
| Phylogeny | 2 | 2020 | 13341 | 0.06 | Why? |
| Humans | 26 | 2021 | 930598 | 0.06 | Why? |
| Sequence Homology, Nucleic Acid | 2 | 2020 | 368 | 0.06 | Why? |
| Fluorescent Antibody Technique | 1 | 2005 | 835 | 0.06 | Why? |
| Apoptosis | 2 | 2021 | 2335 | 0.06 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2004 | 635 | 0.06 | Why? |
| DNA | 1 | 2007 | 778 | 0.06 | Why? |
| Cattle | 1 | 2005 | 1336 | 0.05 | Why? |
| Naphthoquinones | 1 | 2021 | 87 | 0.05 | Why? |
| Circulating MicroRNA | 1 | 2021 | 123 | 0.05 | Why? |
| Half-Life | 1 | 2021 | 298 | 0.05 | Why? |
| Calcium Channels, L-Type | 1 | 2019 | 15 | 0.05 | Why? |
| Nifedipine | 1 | 2019 | 27 | 0.05 | Why? |
| Ubiquinone | 1 | 2020 | 91 | 0.05 | Why? |
| Hydroxybutyrates | 1 | 2020 | 162 | 0.05 | Why? |
| Toxicity Tests | 1 | 2020 | 100 | 0.05 | Why? |
| RNA | 1 | 2007 | 1278 | 0.05 | Why? |
| Crotonates | 1 | 2020 | 141 | 0.05 | Why? |
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2020 | 106 | 0.05 | Why? |
| Cells, Cultured | 3 | 2020 | 5835 | 0.05 | Why? |
| Toluidines | 1 | 2020 | 145 | 0.05 | Why? |
| Membrane Fusion | 1 | 2004 | 713 | 0.05 | Why? |
| Phlebotomus Fever | 1 | 2019 | 44 | 0.05 | Why? |
| Enzyme Assays | 1 | 2020 | 295 | 0.05 | Why? |
| Arenaviruses, New World | 1 | 2018 | 14 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| Arenaviridae | 1 | 2018 | 37 | 0.05 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2020 | 530 | 0.05 | Why? |
| Chromosomes, Artificial | 1 | 2017 | 2 | 0.04 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.04 | Why? |
| Virulence | 2 | 2021 | 2172 | 0.04 | Why? |
| Molecular Dynamics Simulation | 2 | 2021 | 4155 | 0.04 | Why? |
| Autophagosomes | 1 | 2018 | 154 | 0.04 | Why? |
| Tripartite Motif Proteins | 1 | 2017 | 44 | 0.04 | Why? |
| Disease Models, Animal | 3 | 2021 | 10998 | 0.04 | Why? |
| Protein Conformation | 3 | 2021 | 4386 | 0.04 | Why? |
| Spleen | 1 | 2021 | 877 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2020 | 987 | 0.04 | Why? |
| Sf9 Cells | 1 | 2017 | 273 | 0.04 | Why? |
| Bortezomib | 1 | 2017 | 125 | 0.04 | Why? |
| Protein Transport | 1 | 2018 | 487 | 0.04 | Why? |
| Oseltamivir | 1 | 2020 | 583 | 0.04 | Why? |
| RNA Interference | 1 | 2019 | 534 | 0.04 | Why? |
| Ligands | 1 | 2021 | 1300 | 0.04 | Why? |
| GPI-Linked Proteins | 1 | 2017 | 317 | 0.04 | Why? |
| Calcium Channel Blockers | 1 | 2019 | 367 | 0.04 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2017 | 249 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.04 | Why? |
| Mutation Rate | 1 | 2018 | 382 | 0.04 | Why? |
| Cytoplasm | 1 | 2017 | 304 | 0.04 | Why? |
| Yellow Fever | 1 | 2018 | 231 | 0.04 | Why? |
| Imidazoles | 1 | 2021 | 631 | 0.04 | Why? |
| Nitriles | 1 | 2020 | 1053 | 0.04 | Why? |
| DNA Viruses | 1 | 2017 | 184 | 0.04 | Why? |
| Polymerase Chain Reaction | 3 | 2017 | 6740 | 0.04 | Why? |
| Exosomes | 1 | 2021 | 567 | 0.04 | Why? |
| Female | 7 | 2021 | 380317 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2020 | 12361 | 0.04 | Why? |
| Molecular Structure | 1 | 2020 | 1539 | 0.04 | Why? |
| RNA, Small Interfering | 1 | 2019 | 817 | 0.03 | Why? |
| Molecular Docking Simulation | 2 | 2020 | 6902 | 0.03 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2017 | 249 | 0.03 | Why? |
| Circular Dichroism | 2 | 2004 | 154 | 0.03 | Why? |
| Endosomes | 1 | 2018 | 490 | 0.03 | Why? |
| Nuclear Proteins | 1 | 2017 | 321 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2021 | 2739 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2020 | 2219 | 0.03 | Why? |
| Lung | 2 | 2021 | 31049 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2021 | 2689 | 0.03 | Why? |
| Cryoelectron Microscopy | 1 | 2021 | 2372 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.03 | Why? |
| Orthomyxoviridae Infections | 1 | 2020 | 1001 | 0.03 | Why? |
| Administration, Oral | 1 | 2020 | 2340 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Dogs | 1 | 2020 | 2529 | 0.03 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.03 | Why? |
| Pyrimidines | 1 | 2020 | 1557 | 0.03 | Why? |
| Microscopy, Electron | 2 | 2005 | 830 | 0.03 | Why? |
| Antigens, CD | 1 | 2017 | 984 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2018 | 1083 | 0.03 | Why? |
| Testis | 1 | 2017 | 566 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.03 | Why? |
| Interferon-beta | 1 | 2017 | 979 | 0.03 | Why? |
| China | 4 | 2021 | 50654 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2021 | 3786 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2017 | 1276 | 0.03 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.02 | Why? |
| Genome, Viral | 3 | 2020 | 13157 | 0.02 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2021 | 4020 | 0.02 | Why? |
| Drug Approval | 1 | 2017 | 1325 | 0.02 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.02 | Why? |
| Glutathione Transferase | 1 | 2004 | 86 | 0.02 | Why? |
| Immunochemistry | 1 | 2004 | 95 | 0.02 | Why? |
| Chemical Fractionation | 1 | 2004 | 89 | 0.02 | Why? |
| Mutation | 1 | 2005 | 12376 | 0.02 | Why? |
| Chromatin | 1 | 2004 | 107 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Interferon Type I | 1 | 2017 | 2789 | 0.02 | Why? |
| Staining and Labeling | 1 | 2004 | 169 | 0.02 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.02 | Why? |
| Male | 6 | 2021 | 367725 | 0.02 | Why? |
| DNA Primers | 1 | 2007 | 1170 | 0.02 | Why? |
| Sequence Analysis | 1 | 2005 | 496 | 0.02 | Why? |
| HIV Envelope Protein gp41 | 1 | 2004 | 153 | 0.02 | Why? |
| DNA, Complementary | 1 | 2005 | 568 | 0.02 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.01 | Why? |
| Fluorescence | 1 | 2004 | 475 | 0.01 | Why? |
| Surface Plasmon Resonance | 1 | 2004 | 440 | 0.01 | Why? |
| Point Mutation | 1 | 2005 | 481 | 0.01 | Why? |
| Cell Nucleus | 1 | 2004 | 399 | 0.01 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.01 | Why? |
| Exercise | 1 | 2021 | 6771 | 0.01 | Why? |
| Oligopeptides | 1 | 2004 | 576 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2004 | 669 | 0.01 | Why? |
| Protein Structure, Secondary | 1 | 2004 | 1077 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Brain | 1 | 2017 | 5133 | 0.01 | Why? |
| Base Sequence | 1 | 2007 | 3581 | 0.01 | Why? |
| Recombinant Fusion Proteins | 1 | 2004 | 919 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2005 | 3198 | 0.01 | Why? |
| Mutation, Missense | 1 | 2005 | 863 | 0.01 | Why? |
| Molecular Epidemiology | 1 | 2005 | 1638 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.01 | Why? |
| Mitochondria | 1 | 2004 | 857 | 0.01 | Why? |
| Escherichia coli | 1 | 2004 | 1547 | 0.01 | Why? |
| Dose-Response Relationship, Drug | 1 | 2004 | 3776 | 0.01 | Why? |
| Temperature | 1 | 2004 | 2305 | 0.01 | Why? |
| Peptides | 1 | 2004 | 2513 | 0.01 | Why? |
| Anti-HIV Agents | 1 | 2004 | 2209 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Retrospective Studies | 1 | 2019 | 105322 | 0.01 | Why? |
| Viral Proteins | 1 | 2004 | 7370 | 0.00 | Why? |
| Aged | 1 | 2021 | 215776 | 0.00 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 13720 | 0.00 | Why? |
| Adult | 1 | 2021 | 244371 | 0.00 | Why? |
| Middle Aged | 1 | 2021 | 270681 | 0.00 | Why? |
| Adolescent | 1 | 2005 | 86841 | 0.00 | Why? |